To: 	The Copenhagen Stock Exchange

TRANSLATION


Announcement No. 17 in 2007
November 19, 2007




Conference call


Today at 2.00 p.m. (CET), ALK-Abelló holds a conference call for analysts and
investors at which President and CEO Jens Bager and Executive Vice President
R&D, Dr. Henrik Jacobi will review the announcement issued on Friday, November
16, 2007 regarding results from the American Phase III study with the company's
grass tablet. The review will be followed by a Q&A session. 

All participants must call in on tel +45 7026 5040 before 1.55 p.m. (CET). The
conference call will subsequently be available for replay on our website
www.alk-abello.com. 

Further inquiries may also be directed to Investor Relations at
Schering-Plough, Robyn Brown on tel +1 908 298 7417. 



Hørsholm, November 19, 2007
ALK-Abelló A/S



Jens Bager
President and CEO




For further information please contact:
Per Plotnikof, Investor Relations, +45 4574 7527